Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
about
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusionClopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in GermanyDeciphering the Developmental Dynamics of the Mouse Liver TranscriptomePharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis.A Review on Dapsone Hypersensitivity Syndrome Among Chinese Patients with an Emphasis on Preventing Adverse Drug Reactions with Genetic TestingClozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.Nurses' communication of pharmacogenetic test results as part of discharge careNonalcoholic steatohepatitis in precision medicine: Unraveling the factors that contribute to individual variability.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenPediatric perspective on pharmacogenomics.Considerations for rare variants in drug metabolism genes and the clinical implications.Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis.Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases.Advances in the Pharmacogenomics of Adverse Drug Reactions.The role of drug profiles as similarity metrics: applications to repurposing, adverse effects detection and drug-drug interactions.Predictive or not predictive: understanding the mixed messages from the patient's DNA sequence.CSH guidelines for the diagnosis and treatment of drug-induced liver injuryBiomarkers: Delivering on the expectation of molecularly driven, quantitative health.Biomarkers of adverse drug reactions.HLA-B*38:02:01predicts carbimazole/methimazole-induced agranulocytosis
P2860
Q24273350-CE2D61F0-43AB-4122-8A10-9ADB68467297Q26823542-68FA2E1F-3E8E-4265-A123-34BF3D13274EQ28072203-5B4F05C5-44A6-4A43-B55C-90912C31E074Q28550476-8A439B49-CD22-4708-B620-296174AC7621Q33602525-4B9CA368-2C7B-4643-ABC4-8808BAF7D410Q33636804-C0C05C86-89B5-4DB1-B600-B515CD20B2B2Q34138234-D5D8DD33-7CC9-4706-B212-8DE3AAF6E86EQ34646772-CAA5D572-47D3-4345-8D9D-A1BE417FDA41Q35317242-E86EA083-D6A4-49E8-B69A-0F43684C248CQ35689076-D8D96ADA-A55C-4DAF-834D-2F9B2E27D807Q36322918-D5380031-5760-418E-BF1C-9163FC2BCDAFQ38162869-18CDC3FE-C389-4949-A0A9-6C93F254B65FQ38199740-37A56F31-F7C6-4B2C-857D-9282C47AE82BQ38263760-74FABC64-5DDD-4898-965F-963CCF4A4563Q38286234-88260064-4849-472C-88B8-D6684144E176Q38663764-AD1C27D3-622E-4F8D-A173-FC8C36129C41Q38856712-E9BB836B-D32F-4A30-8948-16168531EE93Q38945647-B137F18F-1164-4C91-8016-55BFE7AE42ECQ42354312-692A72A7-DF95-4A35-8EF6-F281DF722A2BQ47377237-77CF06B7-EFAD-4683-BFCC-70F22120FE06Q47928481-B880E9CC-0BD5-4CED-A901-666412B36E6FQ57273952-D080EC21-F31E-44FE-AE76-FEEE2EAA8603
P2860
Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
@en
type
label
Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
@en
prefLabel
Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
@en
P2860
P356
P1476
Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
@en
P2093
Chun-Yu Wei
Ming-Ta Michael Lee
P2860
P304
P356
10.1093/HMG/DDS341
P577
2012-08-19T00:00:00Z